NEW YORK, Aug. 9 (GenomeWeb News) - Shares in Harvard Bioscience sank 6.10 percent, or $.20, to 3.08 in mid-afternoon trading after the company reported a 3.3-percent decline in second-quarter revenue atop a net loss.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Nature this week: genetic history of HIV in the US, and more.
There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.
A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.
Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.